+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antiemetic Drugs Market by Indication, Drug Class, Route Of Administration, End User, Distribution Channel - Global Forecast to 2030- Product Image
Antiemetic Drugs Market by Indication, Drug Class, Route Of Administration, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Antiemetic Drugs Market by Indication, Drug Class, Route Of Administration, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924704
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The antiemetic drugs market is experiencing significant transformation as clinical needs, technological innovation, and regulatory policies converge. Senior decision-makers seeking resilient, informed strategies must navigate a complex landscape of evolving therapies, supply chain risks, and global competition to achieve sustained growth.

Market Snapshot: Antiemetic Drugs Market

The Antiemetic Drugs Market grew from USD 5.92 billion in 2024 to USD 6.44 billion in 2025. It is expected to continue growing at a CAGR of 8.75%, reaching USD 9.80 billion by 2030. This robust trajectory highlights growing demand for advanced antiemetic solutions, driven by a rising incidence of oncology treatments and surgical procedures globally. Stakeholders remain focused on advancing receptor-targeted therapies and seamless patient management strategies as healthcare delivery models evolve.

Scope & Segmentation

This report delivers in-depth analysis across key segmentation dimensions and geographic markets, equipping executives with insights for targeted strategy formation.

  • Indication: Chemotherapy-induced nausea and vomiting, post-operative nausea and vomiting, radiation-induced nausea and vomiting.
  • Drug Class: Corticosteroids, dopamine antagonists, neurokinin 1 receptor antagonists, serotonin 5-HT3 receptor antagonists.
  • Route of Administration: Intravenous and oral formulations, meeting the needs of both inpatient and outpatient settings.
  • End User: Hospitals, clinics, home care settings—each driving different purchasing and utilization priorities.
  • Distribution Channel: Hospital pharmacies, online pharmacies, retail pharmacies, each serving distinct prescriber and patient touchpoints.
  • Regions Covered: Americas (including United States, Canada, Mexico, Brazil, and Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and more), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Leading Companies: Merck & Co., Inc.; Helsinn Healthcare SA; Hoffmann-La Roche AG; GlaxoSmithKline plc; Novartis AG; Teva Pharmaceutical Industries Ltd.; Pfizer Inc.; Dr. Reddy’s Laboratories Ltd.; Mylan N.V.; Sun Pharmaceutical Industries Ltd.

Key Takeaways for Senior Decision-Makers

  • Next-generation receptor antagonists and companion diagnostics are shaping new standards in patient-specific therapy selection, offering differentiated clinical approaches for oncology and surgical protocols.
  • Rising adoption of digital health platforms enables real-time symptom monitoring and faster intervention, improving patient adherence and generating actionable real-world evidence to guide treatment optimization.
  • Several manufacturers are strengthening their supply chain resilience by diversifying sourcing and pursuing vertical integration, aiming to reduce vulnerability to regulatory, tariff, and global distribution challenges.
  • Commercial strategies benefit from integrated value-based contracting and dynamic pricing structures, allowing for better alignment with payer incentives and reimbursement policies across diverse markets.
  • Market entrants and established players are leveraging targeted partnerships—spanning biotech, pharmaceutical companies, and digital providers—to accelerate late-stage development, regulatory approvals, and broad commercial readiness.

Tariff Impact: U.S. Policy Shaping Value Chains

Recent U.S. tariff adjustments have catalyzed shifts in both raw material sourcing and distribution networks for antiemetic drugs. Companies are recalibrating procurement and pricing approaches, expanding regional supplier bases, and engaging in value-based negotiations with payers to absorb cost pressures. These dynamics are also prompting producers to consider vertical integration, securing a more stable supply of key inputs amid economic and geopolitical uncertainty. Operational agility and proactive policy engagement remain critical for maintaining competitiveness in both domestic and international markets.

Methodology & Data Sources

The market analysis integrates primary research—comprising structured interviews with thought leaders, oncologists, and procurement executives—and secondary sources such as regulatory filings, clinical trial registries, industry literature, and proprietary datasets. Data triangulation and validation protocols, including expert panels and cross-referencing, underpin the reliability of insights presented.

Why This Report Matters

  • Empowers executives to develop segmentation-aligned strategies supported by the latest trend analysis and competitive intelligence.
  • Illuminates supply chain vulnerabilities and tariff impacts, enabling risk-aware planning and procurement decisions.
  • Offers actionable insights for aligning commercialization, payer engagement, and product development with emerging therapeutic and regional patterns.

Conclusion

As the antiemetic drugs market evolves in complexity, leaders who prioritize innovation, digital integration, and operational resilience will be well-positioned to capture opportunities and mitigate risks. Informed actions today pave the way for sustainable, patient-centric growth and competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antiemetic Drugs Market, by Indication
8.1. Introduction
8.2. Chemotherapy-Induced Nausea And Vomiting
8.3. Post-Operative Nausea And Vomiting
8.4. Radiation-Induced Nausea And Vomiting
9. Antiemetic Drugs Market, by Drug Class
9.1. Introduction
9.2. Corticosteroids
9.3. Dopamine Antagonists
9.4. Neurokinin 1 Receptor Antagonists
9.5. Serotonin 5-HT3 Receptor Antagonists
10. Antiemetic Drugs Market, by Route Of Administration
10.1. Introduction
10.2. Intravenous
10.3. Oral
11. Antiemetic Drugs Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care Settings
11.4. Hospitals
12. Antiemetic Drugs Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Americas Antiemetic Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Antiemetic Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Antiemetic Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Merck & Co., Inc.
16.3.2. Helsinn Healthcare SA
16.3.3. Hoffmann-La Roche AG
16.3.4. GlaxoSmithKline plc
16.3.5. Novartis AG
16.3.6. Teva Pharmaceutical Industries Ltd.
16.3.7. Pfizer Inc.
16.3.8. Dr. Reddy’s Laboratories Ltd.
16.3.9. Mylan N.V.
16.3.10. Sun Pharmaceutical Industries Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ANTIEMETIC DRUGS MARKET MULTI-CURRENCY
FIGURE 2. ANTIEMETIC DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. ANTIEMETIC DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ANTIEMETIC DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ANTIEMETIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANTIEMETIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY POST-OPERATIVE NAUSEA AND VOMITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY RADIATION-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DOPAMINE ANTAGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY NEUROKININ 1 RECEPTOR ANTAGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. CANADA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. CANADA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 40. CANADA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. CANADA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. MEXICO ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. MEXICO ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 45. MEXICO ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. MEXICO ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. UNITED KINGDOM ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED KINGDOM ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. GERMANY ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. GERMANY ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 71. GERMANY ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. GERMANY ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. GERMANY ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. FRANCE ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. FRANCE ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 76. FRANCE ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. FRANCE ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. FRANCE ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. ITALY ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. ITALY ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 86. ITALY ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. ITALY ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. ITALY ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. SPAIN ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. SPAIN ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 91. SPAIN ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. SPAIN ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. SPAIN ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. SAUDI ARABIA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. SAUDI ARABIA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. SOUTH AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. SOUTH AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. DENMARK ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. DENMARK ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 111. DENMARK ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 112. DENMARK ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. DENMARK ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. NETHERLANDS ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. QATAR ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. QATAR ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 121. QATAR ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 122. QATAR ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. QATAR ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. FINLAND ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. FINLAND ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 126. FINLAND ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. FINLAND ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. FINLAND ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. EGYPT ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. EGYPT ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 141. EGYPT ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. EGYPT ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. EGYPT ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. TURKEY ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. TURKEY ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 146. TURKEY ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 147. TURKEY ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. TURKEY ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. NORWAY ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. NORWAY ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 156. NORWAY ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. NORWAY ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. NORWAY ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. POLAND ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 160. POLAND ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 161. POLAND ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 162. POLAND ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. POLAND ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. SWITZERLAND ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. SWITZERLAND ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 175. CHINA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. CHINA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 177. CHINA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. CHINA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. CHINA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. INDIA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. INDIA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 182. INDIA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 183. INDIA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. INDIA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. JAPAN ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. JAPAN ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 187. JAPAN ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. JAPAN ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. JAPAN ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. THAILAND ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. THAILAND ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 207. THAILAND ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. THAILAND ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. THAILAND ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. SINGAPORE ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. ANTIEMETIC DRUGS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 236. ANTIEMETIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Antiemetic Drugs market report include:
  • Merck & Co., Inc.
  • Helsinn Healthcare SA
  • Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Mylan N.V.
  • Sun Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.44 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.8 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Antiemetics Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Antiemetics Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • 150 Pages
  • Global
From
Antiemetic Drugs - Global Strategic Business Report - Product Image

Antiemetic Drugs - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Antiemetics and Antinauseants Market Report 2025 - Product Image

Antiemetics and Antinauseants Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Antiemetic Drug Market 2024-2028 - Product Image

Antiemetic Drug Market 2024-2028

  • Report
  • 184 Pages
  • Global
From
Postoperative Nausea And Vomiting - Pipeline Insight, 2025 - Product Image

Postoperative Nausea And Vomiting - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From

About the Antiemetic Market

The antiemetic market within the context of gastrointestinal drugs is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat nausea and vomiting. These drugs are used to treat a variety of conditions, including motion sickness, chemotherapy-induced nausea and vomiting, and postoperative nausea and vomiting. Antiemetics are also used to treat nausea and vomiting caused by certain medications, such as opioids. The antiemetic market is highly competitive, with a number of large pharmaceutical companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Novartis, Sanofi, and Takeda Pharmaceuticals. Other companies, such as Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Cipla, also offer antiemetic products. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.